AIGIV

DRUG2 trials

Sponsors

Emergent BioSolutions

Conditions

AnthraxInhalational Anthrax

Unknown Phase

Observational Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Patients With Systemic Anthrax

Not yet recruitingNCT03569514

Emergent BioSolutionsAnthrax

Start: 2026-11-30End: 2027-08-01Target: 10Updated: 2026-02-06

A Field Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Inhalational Anthrax Patients

Not yet recruitingNCT03569553

Emergent BioSolutionsInhalational Anthrax

Start: 2027-05-30End: 2027-07-01Target: 100Updated: 2026-02-06